Breaking News

Ampio Starts Construction of Manufacturing Facility

To produce lead drug candidate Ampion for knee osteoarthritis

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Ampio Pharmaceuticals began construction of its new manufacturing facility in Denver, CO for its lead drug candidate, Ampion, for the treatment of osteoarthritis of the knee. The facility is expected to be ready for production in the summer of 2014 and should generate approximately 40 new jobs in the next two years.   “The construction of this manufacturing facility will accomplish a major milestone for the commercialization of Ampio’s lead drug,” said Michael Macaluso, chairma...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters